Focus on Psoriasis: A Report from the 2022 IPC Think Tank – Miami
Under the title, What’s Next in Psoriasis? From Maintenance to Disease Modification, the 2022 IPC Think Tank scientific symposium was
Tuesday, January 24, 2023
Resource Category: Real-world Evidence
Drug Survival Associated with Effectiveness and Safety of Treatment with Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients with Psoriasis
Real-world evidence studies become crucial to achieving the evidence needed in clinical practice. But how are data evaluated in the
Wednesday, August 31, 2022
Introduction to IPC & Real-world Data in Psoriasis
Dr. Gelfand discusses the difference between Real World Data (RWD) and Real World Evidence (RWE) and the important role they
Wednesday, May 18, 2022
Real World Data and Psoriasis: The United Kingdom and European Perspective
Real World Data and Psoriasis: The United Kingdom and European Perspective Nick Reynolds, BSc, MBBS, MD, FRCP | United Kingdom
Wednesday, May 18, 2022
Real World Data Using Medical and Administrative Records
Real World Data Using Medical and Administrative Records April Armstrong, MD, MPH | United States 2022https://youtu.be/w-Jj_BY_At0
Wednesday, May 18, 2022
